Cardura Xl

   
Google
 
Web NewDrugInformation.com

Cardura Xl


Drug - Cardura Xl
The trade name of the product as shown on the labeling.

Dosage - TABLET, EXTENDED RELEASE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Doxazosin Mesylate
Multiple ingredients are in alphabetical order.

Strength - EQ 4MG BASE
The potency of the active ingredient(s), Doxazosin Mesylate. May repeat for multiple part products.

Applicant - PFIZER
The firm name holding legal responsibility for Cardura Xl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021269
The FDA assigned number to Cardura Xl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Cardura Xl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 22, 2005
The date Cardura Xl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Cardura Xl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Cardura Xl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pfizer Inc
The full name of the firm holding legal responsibility for the new application of Cardura Xl.

Cardura Xl